Journal: Drug Design, Development and Therapy
Article Title: Catalpol Enhances Osteogenic Differentiation of Human Periodontal Stem Cells and Modulates Periodontal Tissue Remodeling in an Orthodontic Tooth Movement Rat Model
doi: 10.2147/DDDT.S482969
Figure Lengend Snippet: CAT promotes the expression of osteogenic differentiation markers in hPDLSCs. ( A ) The protein levels of COL1, ALP, and RUNX2 with CAT (0, 1, 10, 100 μM) after osteogenic induction for 14 days. ( B ) The protein levels of p-AKT and ER-α with CAT (0, 1, 10, 100 μM) after osteogenic induction for 14 days. ( C – E ) The mRNA levels of COL1, ALP, and RUNX2 with CAT (0, 1, 10, 100 μM) after osteogenic induction for 14 days (one-way ANOVA). Error bars stand for mean ± SD. **** P < 0.0001. ( F – J ) Relative quantification of COL1 ( F ), ALP ( G ), RUNX2 ( H ), p-AKT ( I ), and ER-α ( J ) protein levels with CAT (0, 1, 10, 100 μM) after osteogenic induction for 14 days (one-way ANOVA). Error bars stand for mean ± SD. *** P < 0.001, **** P < 0.0001. Each experiment was repeated five times.
Article Snippet: Immerse the slide in a solution containing specific primary antibodies such as polyclonal anti-rabbit RUNX2 (1:200; ImmunoWay, Plano, TX, USA), COL-1 (1:300; Proteintech, Hubei, China), and RANKL (1:300; Solarbio, Beijing, China) antibodies and incubate overnight at 4°C.
Techniques: Expressing, Quantitative Proteomics